update

Panacea Biotec soars on getting nod to raise funds up to Rs 250 crore.

       Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

       Panacea Biotec has received an approval to raise funds by way of issue of equity shares and/or other securities, etc. aggregating up to Rs 250 crore or equivalent thereof in any currency, subject to approval of the shareholders. The board of directors at its meeting held on August 01, 2014 has approved for the same.

       

The promoters holding in the company stood at 74.81% while Institutions and Non-Institutions held 2.25% and 22.94% respectively.

       

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 199.00 on 27-Jun-2014 and a 52 week low of Rs. 82.30 on 19-Aug-2013.

       

Last one week high and low of the scrip stood at Rs. 175.80 and Rs. 161.00 respectively. The current market cap of the company is Rs. 1036.98 crore.

       

The scrip opened at Rs. 161.00 and has touched a high and low of Rs. 175.80 and Rs. 161.00 respectively. So far 14267 shares were traded on the counter.

       

Panacea Biotec is currently trading at Rs. 168.50, up by 4.85 points or 2.93% from its previous closing of Rs. 163.65 on the BSE.